CLINICAL TRIALS PROFILE FOR ROTATEQ
✉ Email this page to a colleague
All Clinical Trials for ROTATEQ
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01259765 ↗ | Llama Antibody, Rotavirus Diarrhoea, Children | Completed | Unilever Nederland Holdings | Phase 2 | 2006-01-01 | The investigators hypothesize that : oral administration of VHH batch 203027 will be - safe and tolerable for healthy Bangladeshi humans of all age groups (Part I) - effective in reducing severity of diarrhoea in children with proven rotavirus infection (Part II). This entry only covers Part II. |
NCT01259765 ↗ | Llama Antibody, Rotavirus Diarrhoea, Children | Completed | International Centre for Diarrhoeal Disease Research, Bangladesh | Phase 2 | 2006-01-01 | The investigators hypothesize that : oral administration of VHH batch 203027 will be - safe and tolerable for healthy Bangladeshi humans of all age groups (Part I) - effective in reducing severity of diarrhoea in children with proven rotavirus infection (Part II). This entry only covers Part II. |
NCT01375907 ↗ | Safety Study of a Rotavirus Vaccine (Rotavin-M1) Among Healthy Adults | Completed | Center for Research and Production of Vaccines and Biologicals | Phase 1 | 2009-08-01 | The purpose of this study is to evaluate the safety of Rotavin-M1 produced by the Center for Research and Production of Vaccines and Biologicals (POLYVAC) in adult volunteers in Vietnam. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ROTATEQ
Condition Name
Clinical Trial Locations for ROTATEQ
Trials by Country
Clinical Trial Progress for ROTATEQ
Clinical Trial Phase
Clinical Trial Sponsors for ROTATEQ
Sponsor Name